Great Valley Advisor Group, Inc. Rallybio Corp Transaction History
Great Valley Advisor Group, Inc.
- $4.07 Billion
- Q4 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Rallybio Corp stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 15,000 shares of RLYB stock, worth $11,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$11,250% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
49Shares Held
32.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$3.15 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.73 Million1.19% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.72 Million1.55% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.48 Million4.27% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2.27 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $24.1M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...